Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Hoopes, Durrie, Rivera Research

Neither a doctor nor a teaching hospital

Research payments

$124,833

32 payments

Through program year 2025, Hoopes, Durrie, Rivera Research is reported as receiving $124,833 in research payments, across 32 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $27,158 11
2024 Research $8,100 4
2023 Research $12,240 6
2022 Research $11,100 2
2021 Research $5,960 3
2020 Research $11,955 5
2019 Research $48,320 1

Breakdown

Who paid Research payments · program years 2019–2025
  1. Glaukos Corporation $49,355 20 payments
  2. Avedro Inc. $48,320 1 payment
  3. Oyster Point Pharma, Inc. $27,158 11 payments
Studies the money was for Research payments · program years 2019–2025
  1. 308 & 401 $48,320 1 payment
  2. OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) $25,662 9 payments
  3. Observational Registry to Assess the Durability of Effect of Corneal Colagen Cross-linking $11,810 6 payments
  4. Observational Registry to Assess the Durability of Effect of Corneal Colagen Cross-linking $9,740 5 payments
  5. A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus $7,515 2 payments
  6. A Phase IV Observational Registry to Assess the Safety and Durability of Effect of Corneal Collagen Cross-linking With Photrexa Viscous, Photrexa, and the KXL System in Patients With Corneal Ectasia Following Refractive Surgery $6,690 4 payments
  7. A Phase 3, Multi-center, Randomized, Double-masked, Placebo/Sham-controlled Study to Evaluate the Safety and Efficacy of Oxygen Enriched, Non-invasive Epithelium-on Corneal Collagen Cross-linking in Eyes with Keratoconus $2,500 1 payment
  8. Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) $1,496 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record